Trending
- TV presenter cuts the ribbon at Medray HQ
- Esaote reflects innovation and empathy through new identity
- Former chair Dobson takes up role as AXREM director of government affairs
- Radiology AI marketplace CARPL.ai aims to accelerate adoption
- How to start your breast AI journey?
- Walk the Walk grant helps cancer charity provide more patient support
- AI tools enable secure monetisation for medical imaging data
- Compact space, big possibilities
- Latest adjustable height trolley from Wardray offers increased weight capacity
- AXREM reaches membership milestone
Molecular imaging using IgG-TAT based radioimmunoconjugates
Author(s): Mathew Veal, Professor Bart Cornelissen
Hospital: University of Oxford, University Medical Centre Groningen
Reference: RAD Magazine, 47, 556, 20-21
Excerpt: Clinical imaging has become a fundamental tool in modern medicine, utilising modalities including CT, MRI, ultrasound, SPECT and PET. The ever-increasing complexity revealed by molecular biology along with the implementation of highly specialised precision therapeutics has created a demand for molecularly targeted imaging devices, also known as molecular imaging.